Thierry Chardès

9PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersTumour immunologyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 21, 2025
Cathepsins: Novel opportunities for antibody therapeutics in cancer.

Timothée David, Pénélope Desroys du Roure, Aude Mallavialle

|Jan 12, 2025
Antibodies against the multifaceted cathepsin D protein open new avenues for TNBC immunotherapy.

Pénélope Desroys du Roure, Timothée David, Aude Mallavialle

|Nov 29, 2023
Anti-cathepsin D immunotherapy triggers both innate and adaptive anti-tumour immunity in breast cancer.

Timothée David, Aude Mallavialle, Julien Faget

|Nov 08, 2022
SPARC in cancer-associated fibroblasts is an independent poor prognostic factor in non-metastatic triple-negative breast cancer and exhibits pro-tumor activity.

Lindsay B Alcaraz, Aude Mallavialle, Caroline Mollevi

|Sep 28, 2021
Improving Biologics' Effectiveness in Clinical Oncology: From the Combination of Two Monoclonal Antibodies to Oligoclonal Antibody Mixtures.

Christel Larbouret, Laurent Gros, André Pèlegrin

|May 17, 2020
Biasing human epidermal growth factor receptor 4 (HER4) tyrosine kinase signaling with antibodies: Induction of cell death by antibody-dependent HER4 intracellular domain trafficking.

Romain Lanotte, Véronique Garambois, Nadège Gaborit

Pageof 2

Frequent Collaborators

4 joint publications

Emmanuelle Liaudet-Coopman

2 joint publications

Aude Mallavialle

2 joint publications

Valérie Laurent-Matha

2 joint publications

Pascal Roger